✦ LIBER ✦

Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia

✍ Scribed by Cantrell, Matthew A.; Baye, Jordan; Vouri, Scott Martin

Book ID: 120448641
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 89 KB
Volume: 33
Category: Article
ISSN: 0277-0008
DOI: 10.1002/phar.1243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tadalafil for benign prostatic hyperplas

Tadalafil for benign prostatic hyperplasia

📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 844 KB

Management of Benign Prostatic Hyperplas

Management of Benign Prostatic Hyperplasia: Role of Phosphodiesterase-5 Inhibitors

✍ Gacci, M.; Carini, M.; Salvi, M.; Sebastianelli, A.; Vignozzi, L.; Corona, G.; M 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 370 KB

1570 TADALAFIL, THE PHOSPHODIESTERASE-5

1570 TADALAFIL, THE PHOSPHODIESTERASE-5 INHIBITOR, ATTENUATES THE CELL GROWTH OF HUMAN BENIGN PROSTATIC HYPERPLASIA XENOGRAFTS IN SUPER-SCID MICE

✍ Kiuchi, Hiroshi; Tsujimura, Akira; Okuda, Hidenobu; Yamamoto, Keisuke; Fukuhara, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

Phosphodiesterase Type 5 Inhibitors for

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

✍ Huang, Shih-Tsung 📂 Article 📅 2010 🏛 Medknow Publications 🌐 English ⚖ 271 KB

Phosphodiesterase 5 inhibitors for lower

Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review

✍ Humberto K. Laydner; Paulo Oliveira; Carlos Roberto A. Oliveira; Tafadzwa P. Mak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Pharmacotherapy of benign prostatic hype

Pharmacotherapy of benign prostatic hyperplasia: Inhibitor of 5 alpha-reductase

✍ Ö. Polat; I. Özbey; O. Gül; A. Demirel; Y. Bayraktar 📂 Article 📅 1997 🏛 Springer Netherlands 🌐 English ⚖ 520 KB